Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

WuXi AppTec

Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services from discovery to commercialization.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

WuXi AppTec
2540 Executive Drive, St. Paul, MN 55120, USA
+1 888- 794-0077
Contact WuXi AppTec
Website

 Latest Content from PMHub 

Older trial participants reject bad design, not technology

White Papers and Resources | July 8, 2026 | Cuttsy + Cuttsy

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

White Papers and Resources | July 2, 2026 | Cuttsy + Cuttsy

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.

Press Releases | July 2, 2026 | Medscape Education

Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at...

Moving Beyond the 10%: A New Era in Preterm Birth Prevention

Press Releases | July 1, 2026 | Medscape Education

For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause...

It’s time to stop calling adverse events ‘manageable’

White Papers and Resources | June 29, 2026 | Cuttsy + Cuttsy

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

Supporting our team with an award-winning mental health strategy

Press Releases | June 26, 2026 | Mednet

Mental health has been at the centre of our business since our inception. But that work doesn't just extend to our client projects. Find out more about our award-winning mental...

The value: why localisation pays off across global trials

White Papers and Resources | June 26, 2026 | Cuttsy + Cuttsy

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026

Press Releases | June 24, 2026 | Genesis Research Group

Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...

Medscape Education to Showcase the Impact of Neurology CME at EAN 2026

Press Releases | June 23, 2026 | Medscape Education

Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...

Designing Pharma Stands That People Actually Want to Step Onto

Press Releases | June 18, 2026 | Apex Events and Exhibitions

Exhibition halls are busy environments where delegates move quickly, often with limited time. For pharmaceutical companies, this presents a challenge: how do you create a stand that invites meaningful engagement...